A randomized controlled trial of larval therapy for the debridement of leg ulcers: Results of a multicenter, randomized, controlled, open, observer blind, parallel group study

Wound Repair and Regeneration

Volumn 22, Issue 1, 2014, Pages 43-51

  Mudge, Elizabeth ^a   Price, Patricia ^a   Neal, Walkley ^a   Harding, Keith G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DEBRIDEMENT; FEMALE; FOAM DRESSING; HUMAN; HYDROGEL; LEG ULCER; MAGGOT THERAPY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PAIN; PATIENT COMFORT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; VERY ELDERLY; WOUND DRESSING;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BANDAGES; BIOLOGICAL THERAPY; COST-BENEFIT ANALYSIS; DEBRIDEMENT; FEMALE; HUMANS; HYDROGEL; LARVA; LEG ULCER; MALE; MIDDLE AGED; PAIN; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SATISFACTION; QUESTIONNAIRES; SINGLE-BLIND METHOD; TREATMENT OUTCOME; WOUND HEALING;

EID: 84891829151     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12127     Document Type: Article

References (32)

1. Guthrie HC, Clasper JC,. Historical origins and current concepts of wound debridement. J R Army Med Corps 2011; 157: 130-132.
2. Posnett J, Franks PJ,. The costs of skin breakdown and ulceration in the UK. In:, Pownall M, editor. Skin breakdown: the silent epidemic. Hull, UK: Smith & Nephew Healthcare Ltd., 2007.
3. Drew P, Posnett J, Rusling L,. The cost of wound care for a local population in England. Int Wound J 2007; 4: 129-155.
4. Persoon A, Heinen MM, van der Vleuten CJ, de Rooij MJ, van de Kerkhof PC, van Achterberg T,. Leg ulcers: a review of their impact on daily life. J Clin Nurs 2004; 13: 341-354.
5. White R, Cutting K,. Critical colonisation of chronic wounds: microbial mechanisms. Wounds UK 2008; 4: 70-78.
6. Davies SC, Ricotti C, Cazzaniga A, Welsh E, Eaglstein WH, Mertz PM,. Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo. Wound Repair Regen 2007; 16: 23-29.
7. James GA, Swogger E, Wolcott R, Pulcini E, Secor P, Sestrich J, et al. Biofilms in chronic wounds. Wound Repair Regen 2008; 16: 37-44.
8. Wolcott R, Cutting KF, Dowd SE,. Surgical site infections: biofilms, dehiscence and delayed healing. Wounds UK 2008; 4: 108-113.
9. Van der Plas M, Jukema G, Wai SW, Dogterom-Ballering HC, Lagendijk EL, van Gulpen C, et al. Maggot excretions/secretions are differently effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother 2008; 61: 117-122.
10. Cazander G, Pawiroredjo JS, Vandenbroucke-Grauls CMJE, Schreurs MWJ, Jukema GN,. Synergism between maggot excresions and antibiotics. Wound Repair Regen 2010; 18: 637-642.
11. Cowen LJ, Stechmiller JK, Phillips P, Yang Q, Schultz G,. Chronic wounds, biofilms and use of medicinal larvae. Ulcers Article ID 487024, 7 pages, 2013.
12. Brown A, Horobin A, Blount DG, Hill PJ, English J, Rich A, et al. Blow fly Lucilia sericata nuclease digests DANN associated with wound slough/eschar and with Pseudomonas aeruginosa biofilm. Med Vet Entomol 2012; 26: 432-439.
13. Vowden K, Vowden P,. Wound debridement Part 1: non-sharp techniques. J Wound Care 1999; 8: 237-240.
14. Vowden K, Vowden P,. Wound debridement Part 2: sharp techniques. J Wound Care 1999; 8: 291-294.
15. Leaper D,. Sharp technique for wound debridement. 2002. Available at http://www.worldwidewounds.com/2002/december/Leaper/Sharp-Debridement.html (accessed November 1, 2013).
16. Strohal R, Dissemond J, O'Brien JJ, Piaggesi A, Rimdeika R, Young T, et al. EWMA document: debridement. An updated overview and clarification of the principle role of debridement. J Wound Care 2013; 22: S1-52.
17. Bradley M, Cullum N, Sheldon T,. The debridement of chronic wounds: a systematic review. Health Technol Assess 1999; 3 (Pt 1): 17.
18. Lewis R, Whiting P, ter Riet G, O'Meara S, Glanville J,. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of debriding agents in treating surgical wounds healing by secondary intention. Health Technol Assess 2001; 5: 1-131.
19. Jones V, Grey J, Harding K,. Wound dressings. In:, Grey JE, and, Harding KG, editors. ABC of wound healing. London: BMJ Books; Blackwell Publications, 2006: 777-780.
20. Wayman J, Nirojogi V, Walker A, Sowinski A, Walker MA,. The cost effectiveness of larval therapy in venous ulcers. J Tissue Viability 2000; 10: 91-94.
21. Thomas S, Andrews A, Jones M,. The use of larval therapy in wound management. J Wound Care 1998; 7: 21-24.
22. Hobson RP,. On an enzyme from blow-fly larvae (Lucilia sericata) which digests collagen in alkaline solution. Biochem J 1931; 25: 1458-1463.
23. Vistnes LM, Lee R, Ksander GA,. Proteolytic activity of blowfly larvae secretions in experimental burns. Surgery 1981; 90: 835-841.
24. Schmidtchen A, Wolff H, Rydengard V, Hansson C,. Detection of serine proteases secreted by Lucilia sericata in vitro and during treatment of a chronic leg ulcer. Acta Derm Venereol 2003; 83: 310-311.
25. Telford G, Brown A, Seabra R, Horobin AJ, Rich A, English JS, et al. Degradation of eschar from venous leg ulcers using a recombinant chymotrypsin from Lucilia sericata. Br J Dermatol 2010; 163: 523-531.
26. Pritchard DI, Telford G, Diab M, Low W,. Expression of cGMP compatible Lucilia sericata insect serine proteinase debridement enzyme. Biotechnol Prog 2012; 28: 567-572.
27. Horobin AJ, Shakesheff KM, Pritchard DI,. Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon the migration of human dermal fibroblasts over a fibronectin-coated surface. Wound Repair Regen 2005; 13: 422-433.
28. Cazander G, Gottrup F, Jukema GN,. Maggot therapy for wound healing: clinical relevance, mechanisms of action and future prospects. J Wound Technol 2009; 5: 18-23.
29. Cazander G, van de Veerdonk MC, Vandenbroucke-Grauls CMJE, Schreurs MWJ, Jukema GN,. Maggot excretions inhibit biofilm formation on biomaterials. Clin Orthop Relat Res 2010; 468: 2789-2796.
30. Dumville JC, Worthy G, Soares MO, Bland JM, Cullum N, Dowson C, et al. VenUS II: a randomized controlled trial of larval therapy in the management of leg ulcers. Health Technol Assess 2009; 13: 1-182.
31. Margolis DJ, Bilker W, Santanna J, Baumgarten M,. Venous leg ulcer: incidence and prevalence in the elderly. J Am Acad Dermatol 2002; 46: 381-386.
32. Forssgren A, Fransson I, Nelzen O,. Leg ulcer point prevalence can be decreased by a broad-scale intervention: a follow-up cross sectional study of a defined geographical population. Acta Derm Venerol 2008; 88: 253-256.